Zacks Small-Cap Research has begun covering NewGen

BANGKOK, Oct. 10, 2025 — NewGenIvf Group Limited (NASDAQ: NIVF) (“NewGen” or the “Company”), an advanced, diversified, multi-jurisdictional high-growth enterprise that is transforming industries through innovative solutions in real estate development, digital asset management, and reproductive health, today announced that Zacks Small-Cap Research (“Zacks”) has initiated equity research coverage on the Company. The complete equity research report is available on the Zacks website .

About NewGen
NewGenIVF Group is a technologically forward, diversified, multi-jurisdictional high-growth entity that capitalizes on emerging opportunities across real estate development, digital asset innovation, and reproductive health solutions. The Company operates through three strategic business divisions, each leveraging cutting-edge technology and innovative solutions to foster sustainable growth and high ROI for shareholders across diverse global markets. These divisions include: “NewGenProperty”, which manages profitable real estate development projects in the UAE’s Ras Al Khaimah Emirate; “NewGenDigital”, serving as the Company’s digital asset and DeFi solutions arm; and “NewGenSup”, which focuses on health and longevity products and services. NewGen’s foundational business involves providing leading IVF and assisted reproductive treatment services throughout Asia. With operations spanning numerous jurisdictions and a commitment to innovative, technology-enabled solutions, NewGenIVF Group is uniquely positioned to leverage the convergence of real estate, healthcare, and digital asset opportunities in the evolving global economy.

To learn more, visit . The information contained on, or accessible through, NewGen’s website is not incorporated by reference into this press release, and should not be considered part of this press release.

Investor Relations Contact
ICR, LLC
Robin Yang
Phone: +1 (212) 537-4406
Email: